EUVIMEDEUVIMED entdecken
Crossref

Combined Treatment of Caffeic Acid Phenethyl Ester With Docetaxel Inhibits Survival of Non-small-cell Lung Cancer Cells via Suppression of c-MYC

Li-Kuo Kuo, Yu-Ke Fu, Chien-Chih Yeh, Ching-Yi Lee, Chi-Jung Chung, Li-Jane Shih, Hsin-Ying Lu, Chih-Pin Chuu

Anticancer Research · 2024

DOI: 10.21873/anticanres.17317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Li-Kuo Kuo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Caffeic Acids, Phenylethyl Alcohol, Docetaxel, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caffeic AcidsPhenylethyl AlcoholDocetaxelCarcinoma, Non-Small-Cell LungLung NeoplasmsProto-Oncogene Proteins c-mycCell ProliferationCell SurvivalApoptosisHumansCell Line, TumorProto-Oncogene MasTaxoidsAntineoplastic Combined Chemotherapy ProtocolsGene Expression Regulation, NeoplasticA549 CellsDrug Synergism

Stichwörter der Autor:innen

NSCLCapoptosisc-MYCcaffeic acid phenethyl esterdocetaxel

Substanzen

Caffeic AcidsPhenylethyl Alcoholcaffeic acid phenethyl esterDocetaxelProto-Oncogene Proteins c-mycMYC protein, humanProto-Oncogene MasTaxoidsMAS1 protein, human

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan, R.O.C.
  • Department of Nursing, Mackay Medical College, New Taipei City, Taiwan, R.O.C.
  • Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan, R.O.C.
  • Department of Education and Medical Research, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan, R.O.C.
  • Division of Colon and Rectal Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, R.O.C.

Zitieren

APA

Kuo, L. K., Fu, Y. K., Yeh, C. C., Lee, C. Y., Chung, C. J., Shih, L. J., Lu, H. Y., & Chuu, C. P. (2024). Combined Treatment of Caffeic Acid Phenethyl Ester With Docetaxel Inhibits Survival of Non-small-cell Lung Cancer Cells via Suppression of c-MYC. Anticancer Research. https://doi.org/10.21873/anticanres.17317

Vancouver

Kuo LK, Fu YK, Yeh CC, Lee CY, Chung CJ, Shih LJ, et al. Combined Treatment of Caffeic Acid Phenethyl Ester With Docetaxel Inhibits Survival of Non-small-cell Lung Cancer Cells via Suppression of c-MYC. Anticancer Research. 2024. doi:10.21873/anticanres.17317

BibTeX
@article{Kuo2024,
  author = {Kuo, Li-Kuo and Fu, Yu-Ke and Yeh, Chien-Chih and Lee, Ching-Yi and Chung, Chi-Jung and Shih, Li-Jane and Lu, Hsin-Ying and Chuu, Chih-Pin},
  title = {Combined Treatment of Caffeic Acid Phenethyl Ester With Docetaxel Inhibits Survival of Non-small-cell Lung Cancer Cells via Suppression of c-MYC},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17317}
}
Kostenlos starten →